Search Results 521-530 of 19044 for creatine

1. A Study of Varenicline in the Treatment of Visceral Sensation - Mayo Clinic

   ... creatinine clearance <15 mL/min; Concomitant use of strong CYP3A4 inhibitors and strong or moderate CYP3A4 inducers. Note: Other protocol defined Inclusion ...

2. MELD Score and 90-Day Mortality Rate for Alcoholic Hepatitis - Medical Professionals - Mayo Clinic

   Results should be discussed with patients when presenting prognoses or treatment recommendations. Please enter values for INR, bilirubin, and creatinine in the ...

3. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion - Mayo Clinic

   Chronic kidney disease with creatinine clearance of less than 30mL/min; History of antiphospholipid syndrome, in particular triple positive (lupus ...

4. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   creatinine ≤ 1.5 x upper limit of normal (ULN);; aspartate aminotransferase AST (SGOT) ≤ 3 x ULN (≤ 5 x ULN when HCC or hepatic metastases are present); ...

5. A Study of Ramucirumab Plus Docetaxel in Patients With Urothelial Cancer - Mayo Clinic

   Have adequate renal function as defined by creatinine clearance >30 milliliters/minute. Have urinary protein ≤1+ on dipstick or routine urinalysis. The ...

6. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

   Hemoglobin: ≥ 8.5 g/dL; White blood cells (WBC): > 3.5 x 103/μL; Neutrophils: >1.5 x 103/μL; Platelets: > 100 x 103/μL; Serum creatinine: < 1.7 mg/dL ...

7. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

   Calculated creatinine clearance ≥ 30 mL/min (as calculated by the Cockcroft-Gault formula). ECOG performance status ≤ 2. Male or female ≥ 18 years of age ...

8. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Creatinine clearance (CrCl) ≥ 30 ml/min measured by 24-hour urine collection or estimated by the Cockcroft-Gault formula. Adequate hepatic parameters ...

9. A Study to Evaluate the Safety of Lixivaptan in Subjects Previously Treated with Tolvaptan for Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Advanced diabetes (e.g., glycosylated hemoglobin [HgbA1c] > 7.5%, and/or glycosuria by dipstick, significant proteinuria [>300 mcg albumin/mg creatinine ...

10. Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer - Mayo Clinic

    Creatinine =< 1.5 x ULN OR calculated creatinine clearance >= 50 ml/min using the Cockcroft-Gault formula; Prothrombin time (PT)/activated partial ...